Paramore Miriam J's Form 4 filing
OptimizeRx Corp (OPRX) · filed Jul 2, 2021
- Accession no.
- 0001213900-21-035593
- Filed
- Jul 2, 2021
- Trade date
- Jul 2, 2021
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $867.1K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Paramore Miriam JCIK 0001713156 | Officer (PRESIDENT AND CSO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 2, 2021 | Common Stock | MOption exerciseAcquired | +15,000 | $3.15 | +$47,250 | 22,412 | Direct | |
| Jul 2, 2021 | Common Stock Pursuant to 10B5-1 Plan | SSaleDisposed | −15,000 | $57.81 | −$867,150 | 7,412 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 2, 2021 | Common Stock | MOption exerciseDisposed | −15,000 | $0.00 | $0 | 225,985 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.